Income statement, balance sheet and cash flow statement for the last 3 fiscal years, taken from the XBRL data Charming Medical Ltd files with the SEC in its annual reports.
In USD millions, except per-share amounts. Outflows in the cash flow statement are negative.
Income statement
FY2024
FY2026
FY2026
Revenue
6.02
6.22
4.81
Cost of revenue
0.01
0.02
0.04
Gross profit
6
6.21
4.77
Selling and marketing
0.86
1
0.8
Operating expenses
5.01
4.83
4.84
Operating income
1.01
1.39
-0.03
Interest expense
0.03
0.02
0.02
Interest income
0.02
0.06
0.07
Other non-operating income
-0.01
0.05
0.16
Pre-tax income
1
1.44
0.13
Income tax
0.18
0.24
0.16
Net income to minority interests
0.04
Net income
0.78
1.2
-0.02
EBITDA
1.4
1.65
0.19
EPS, basic
0.05
0.08
0.00
EPS, diluted
0.05
0.08
0.00
Shares, basic (weighted)
15.3
15.3
16.2
Shares, diluted (weighted)
15.3
15.3
16.2
Balance sheet
FY2024
FY2026
FY2026
Cash and equivalents
2.1
0.82
4.7
Receivables
0.4
0.2
Inventory
0.03
0.03
Total current assets
3.37
8.17
Property, plant and equipment
0.5
0.61
Lease right-of-use assets
0.71
0.72
Total assets
5.36
9.87
Accounts payable
0
0.02
Deferred revenue
4.5
3.46
3.05
Short-term debt
0.31
0.19
Total current liabilities
4.95
4.33
Lease liabilities
0.26
0.36
Total liabilities
5.31
4.69
Total debt
0.19
Paid-in capital
0.31
5.1
Retained earnings
0.12
0.1
Other comprehensive income
-0
-0.01
Shareholders' equity
0.05
5.18
Total equity
-1.15
0.05
5.18
Total liabilities and equity
5.36
9.87
Cash flow statement
FY2024
FY2026
FY2026
Net income
0.82
1.2
-0.02
Depreciation and amortization
0.39
0.26
0.22
Deferred income tax
0.06
0.13
0.07
Change in receivables
-0.16
-0.04
0.19
Change in inventory
0.04
0
0
Cash from operations
0.3
0.43
-1.22
Capital expenditures
-0.21
-0.29
-0.34
Purchases of investments
-0.5
-0.01
Cash from investing
-0.21
-2.23
-0.18
Cash from financing
0.1
0.52
5.29
Exchange rate effect
-0.01
-0
-0.01
Net change in cash
0.18
-1.28
3.9
Free cash flow
0.08
0.14
-1.56
Interest paid
0.03
0.02
0.02
Key metrics
Worked out from the statements above. Latest values use fiscal 2026. Valuation uses the share price of $29.36 on July 7, 2026.
Profitability
Metric
Value
How it is calculated
Gross margin
99.3%
Gross profit / revenue.
Operating margin
-0.6%
Operating income / revenue.
EBITDA margin
3.9%
EBITDA (operating income + depreciation and amortization) / revenue.
Pre-tax margin
2.8%
Pre-tax income / revenue.
Net margin
-0.5%
Net income / revenue.
FCF margin
-32.4%
Free cash flow (cash from operations - capital expenditures) / revenue.
Operating cash flow margin
-25.3%
Cash from operations / revenue.
Effective tax rate
117.0%
Income tax / pre-tax income, when pre-tax income is positive.
Return on equity (ROE)
-0.9%
Net income / average shareholders' equity (opening and closing). Not shown when equity is negative.
Return on assets (ROA)
-0.3%
Net income / average total assets.
Capex / revenue
7.1%
Capital expenditures / revenue.
D&A / revenue
4.5%
Depreciation and amortization / revenue.
Growth
Metric
Value
How it is calculated
Revenue growth, 1y
-22.7%
Revenue vs the same period a year earlier. Only from a positive base.
Gross profit growth, 1y
-23.1%
Gross profit vs the same period a year earlier. Only from a positive base.
Operating income growth, 1y
-102.1%
Operating income vs the same period a year earlier. Only from a positive base.
EBITDA growth, 1y
-88.7%
EBITDA vs the same period a year earlier. Only from a positive base.
Net income growth, 1y
-101.9%
Net income vs the same period a year earlier. Only from a positive base.
EPS growth, 1y
-100.0%
EPS vs the same period a year earlier. Only from a positive base.
Operating cash flow growth, 1y
-385.5%
Operating cash flow vs the same period a year earlier. Only from a positive base.
Free cash flow growth, 1y
-1,224.0%
Free cash flow vs the same period a year earlier. Only from a positive base.
Book value growth, 1y
10,421.0%
Book value vs the same period a year earlier. Only from a positive base.
Total assets growth, 1y
84.3%
Total assets vs the same period a year earlier. Only from a positive base.
Share count change, 1y
5.3%
Change in diluted weighted shares vs a year earlier. Negative means buybacks shrank the share count; positive means dilution.
Balance sheet health
Metric
Value
How it is calculated
Current ratio
1.89x
Current assets / current liabilities.
Quick ratio
1.13x
(Cash + short-term investments + receivables) / current liabilities.
Cash ratio
1.08x
(Cash + short-term investments) / current liabilities.
Debt / equity
0.04x
Total debt / shareholders' equity. Not shown when equity is negative.
Debt / assets
1.9%
Total debt / total assets.
Liabilities / assets
47.5%
Total liabilities / total assets.
Net debt
-$4.5M
Total debt - cash - short-term investments. Negative means more cash than debt.
Net debt / EBITDA
-24.2x
Net debt / EBITDA (twelve months), when EBITDA is positive.
Days inventory + days sales outstanding - days payables.
Per share
Metric
Value
How it is calculated
EPS, diluted
$0.00
Net income per diluted share, as reported (split-adjusted). Over the last twelve months: the four quarters summed, or net income / latest diluted shares when a quarter has no reported EPS.
EPS, basic
$0.00
Net income per basic share, as reported (split-adjusted).
Revenue per share
$0.30
Revenue / diluted weighted shares.
FCF per share
-$0.10
Free cash flow / diluted weighted shares.
Operating cash flow per share
-$0.08
Cash from operations / diluted weighted shares.
Book value per share
$0.32
Shareholders' equity / shares outstanding (diluted weighted shares when not reported).
What was Charming Medical Ltd's revenue in fiscal 2026?
Charming Medical Ltd reported revenue of $4.8M for fiscal 2026, 22.7% lower than the year before.
Was Charming Medical Ltd profitable in fiscal 2026?
No. It reported a net loss of $22.6K.
How much free cash flow did Charming Medical Ltd generate in fiscal 2026?
Cash from operations of $1.2M minus capital expenditures of $339.6K left free cash flow of -$1.6M.
Source: SEC EDGAR XBRL company facts. Where a company tags only year-to-date figures, quarters are worked out as differences. Where a line is not tagged it is left empty, never estimated.